Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Price:
16.79
CNY
0.42%
Market Closed
Market Cap:
¥33.2B
Add
Note
Why Create Notes?
Capture your thoughts
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Beijing Tiantan Biological Products Corp Ltd
16.79
+0.07 (+0.42%)
| 52 Week Range |
16.13
23.17
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Delete Alert
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Beijing Tiantan Biological Products Corp Ltd
Beijing Tiantan Biological Products Corp Ltd
Balance Sheet Decomposition is not available for
Beijing Tiantan Biological Products Corp Ltd
Beijing Tiantan Biological Products Corp Ltd
Balance Sheet
Beijing Tiantan Biological Products Corp Ltd
Beijing Tiantan Biological Products Corp Ltd
Currency: CNY
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
54
|
85
|
246
|
192
|
230
|
153
|
157
|
180
|
345
|
322
|
334
|
409
|
675
|
953
|
564
|
670
|
1 919
|
1 250
|
1 412
|
1 748
|
3 317
|
2 194
|
2 833
|
1 423
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
4
|
3
|
5
|
6
|
3 317
|
2 194
|
2 833
|
1 423
|
|
| Cash Equivalents |
54
|
85
|
246
|
192
|
230
|
153
|
157
|
180
|
344
|
322
|
334
|
409
|
674
|
953
|
563
|
668
|
1 915
|
1 246
|
1 407
|
1 742
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
41
|
45
|
57
|
55
|
78
|
131
|
125
|
135
|
146
|
160
|
274
|
377
|
370
|
292
|
230
|
316
|
319
|
450
|
659
|
713
|
1 050
|
1 201
|
133
|
1 134
|
|
| Accounts Receivables |
35
|
43
|
54
|
54
|
76
|
128
|
119
|
128
|
134
|
135
|
212
|
304
|
320
|
218
|
150
|
213
|
6
|
6
|
9
|
12
|
10
|
33
|
18
|
203
|
|
| Other Receivables |
6
|
2
|
3
|
1
|
3
|
2
|
6
|
8
|
12
|
25
|
63
|
73
|
51
|
74
|
80
|
103
|
313
|
444
|
650
|
700
|
1 040
|
1 168
|
115
|
931
|
|
| Inventory |
122
|
118
|
138
|
129
|
131
|
216
|
249
|
448
|
484
|
519
|
562
|
771
|
879
|
814
|
944
|
1 031
|
1 582
|
1 709
|
1 950
|
2 172
|
2 144
|
2 332
|
2 844
|
3 869
|
|
| Other Current Assets |
4
|
8
|
17
|
6
|
7
|
17
|
12
|
75
|
83
|
111
|
16
|
23
|
25
|
20
|
20
|
27
|
26
|
24
|
26
|
24
|
1 035
|
1 544
|
1 759
|
1 296
|
|
| Total Current Assets |
221
|
256
|
457
|
382
|
446
|
517
|
543
|
837
|
1 058
|
1 112
|
1 187
|
1 580
|
1 949
|
2 080
|
1 758
|
2 043
|
3 846
|
3 433
|
4 046
|
4 656
|
7 546
|
7 271
|
7 569
|
7 722
|
|
| PP&E Net |
211
|
223
|
254
|
304
|
306
|
362
|
387
|
714
|
782
|
964
|
1 522
|
2 815
|
3 296
|
3 546
|
3 478
|
3 453
|
981
|
1 121
|
1 602
|
2 075
|
2 872
|
4 202
|
5 014
|
5 891
|
|
| PP&E Gross |
211
|
223
|
254
|
304
|
306
|
362
|
387
|
714
|
782
|
964
|
1 522
|
2 815
|
3 296
|
3 546
|
3 478
|
3 453
|
981
|
1 121
|
1 602
|
2 075
|
2 872
|
4 202
|
5 014
|
5 891
|
|
| Accumulated Depreciation |
102
|
115
|
130
|
147
|
170
|
202
|
232
|
357
|
394
|
457
|
521
|
598
|
647
|
739
|
849
|
1 091
|
878
|
989
|
1 064
|
1 160
|
1 288
|
1 545
|
1 749
|
2 290
|
|
| Intangible Assets |
11
|
11
|
35
|
26
|
17
|
16
|
18
|
63
|
141
|
218
|
213
|
214
|
210
|
204
|
192
|
212
|
240
|
287
|
331
|
394
|
701
|
930
|
1 050
|
1 308
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
94
|
94
|
96
|
115
|
115
|
128
|
174
|
174
|
572
|
|
| Long-Term Investments |
18
|
15
|
12
|
9
|
0
|
13
|
21
|
51
|
66
|
62
|
61
|
48
|
48
|
47
|
83
|
80
|
77
|
82
|
133
|
194
|
222
|
218
|
215
|
208
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
42
|
81
|
101
|
126
|
86
|
114
|
99
|
242
|
149
|
132
|
138
|
121
|
131
|
22
|
49
|
87
|
107
|
109
|
134
|
166
|
168
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
94
|
94
|
96
|
115
|
115
|
128
|
174
|
174
|
572
|
|
| Total Assets |
460
N/A
|
505
+10%
|
759
+50%
|
763
+0%
|
849
+11%
|
1 008
+19%
|
1 095
+9%
|
1 751
+60%
|
2 161
+23%
|
2 455
+14%
|
3 224
+31%
|
4 806
+49%
|
5 635
+17%
|
6 015
+7%
|
5 632
-6%
|
6 013
+7%
|
5 260
-13%
|
5 067
-4%
|
6 314
+25%
|
7 541
+19%
|
11 578
+54%
|
12 929
+12%
|
14 188
+10%
|
15 870
+12%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
5
|
16
|
11
|
11
|
4
|
6
|
4
|
20
|
41
|
40
|
33
|
42
|
58
|
43
|
46
|
57
|
58
|
43
|
44
|
45
|
73
|
69
|
74
|
76
|
|
| Accrued Liabilities |
22
|
18
|
28
|
23
|
29
|
45
|
42
|
51
|
395
|
49
|
48
|
67
|
155
|
78
|
77
|
85
|
41
|
39
|
40
|
42
|
62
|
99
|
98
|
119
|
|
| Short-Term Debt |
114
|
134
|
80
|
15
|
0
|
130
|
140
|
295
|
426
|
524
|
402
|
560
|
240
|
280
|
413
|
370
|
332
|
31
|
6
|
212
|
11
|
27
|
119
|
20
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
30
|
0
|
240
|
9
|
530
|
1 346
|
170
|
162
|
0
|
0
|
0
|
126
|
125
|
124
|
18
|
9
|
|
| Other Current Liabilities |
32
|
29
|
40
|
34
|
60
|
67
|
57
|
98
|
161
|
218
|
224
|
934
|
866
|
804
|
717
|
565
|
172
|
369
|
562
|
515
|
539
|
838
|
970
|
896
|
|
| Total Current Liabilities |
173
|
197
|
159
|
84
|
93
|
248
|
243
|
473
|
1 053
|
830
|
947
|
1 611
|
1 849
|
2 551
|
1 423
|
1 238
|
602
|
482
|
652
|
939
|
810
|
1 157
|
1 280
|
1 120
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
125
|
30
|
360
|
708
|
1 300
|
1 459
|
1 045
|
1 780
|
1 912
|
200
|
231
|
401
|
475
|
384
|
279
|
24
|
45
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
10
|
11
|
20
|
31
|
29
|
62
|
|
| Minority Interest |
1
|
1
|
1
|
1
|
1
|
53
|
78
|
126
|
151
|
87
|
157
|
223
|
250
|
277
|
295
|
280
|
782
|
976
|
1 239
|
1 513
|
2 215
|
2 560
|
2 932
|
3 394
|
|
| Other Liabilities |
0
|
0
|
0
|
42
|
87
|
109
|
138
|
97
|
129
|
122
|
124
|
118
|
150
|
202
|
193
|
238
|
4
|
4
|
75
|
85
|
97
|
106
|
101
|
109
|
|
| Total Liabilities |
174
N/A
|
197
+13%
|
160
-19%
|
126
-21%
|
180
+43%
|
409
+127%
|
458
+12%
|
821
+79%
|
1 362
+66%
|
1 400
+3%
|
1 935
+38%
|
3 252
+68%
|
3 709
+14%
|
4 075
+10%
|
3 690
-9%
|
3 671
-1%
|
1 592
-57%
|
1 696
+7%
|
2 376
+40%
|
3 023
+27%
|
3 526
+17%
|
4 134
+17%
|
4 365
+6%
|
4 731
+8%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
192
|
192
|
217
|
326
|
326
|
326
|
326
|
488
|
488
|
516
|
516
|
516
|
516
|
516
|
516
|
516
|
670
|
871
|
1 045
|
1 254
|
1 373
|
1 648
|
1 648
|
1 977
|
|
| Retained Earnings |
43
|
64
|
88
|
124
|
154
|
81
|
117
|
159
|
264
|
439
|
621
|
875
|
1 247
|
1 264
|
1 274
|
1 521
|
2 116
|
2 226
|
2 619
|
2 989
|
3 612
|
4 355
|
5 382
|
6 698
|
|
| Additional Paid In Capital |
52
|
52
|
294
|
186
|
189
|
192
|
195
|
283
|
46
|
100
|
152
|
164
|
164
|
164
|
164
|
316
|
882
|
275
|
275
|
275
|
3 067
|
2 793
|
2 793
|
2 463
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
12
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
287
N/A
|
308
+7%
|
599
+95%
|
636
+6%
|
669
+5%
|
599
-10%
|
637
+6%
|
930
+46%
|
799
-14%
|
1 055
+32%
|
1 289
+22%
|
1 554
+21%
|
1 926
+24%
|
1 941
+1%
|
1 942
+0%
|
2 342
+21%
|
3 668
+57%
|
3 371
-8%
|
3 939
+17%
|
4 518
+15%
|
8 052
+78%
|
8 795
+9%
|
9 823
+12%
|
11 139
+13%
|
|
| Total Liabilities & Equity |
460
N/A
|
505
+10%
|
759
+50%
|
763
+0%
|
849
+11%
|
1 008
+19%
|
1 095
+9%
|
1 751
+60%
|
2 161
+23%
|
2 455
+14%
|
3 224
+31%
|
4 806
+49%
|
5 635
+17%
|
6 015
+7%
|
5 632
-6%
|
6 013
+7%
|
5 260
-13%
|
5 067
-4%
|
6 314
+25%
|
7 541
+19%
|
11 578
+54%
|
12 929
+12%
|
14 188
+10%
|
15 870
+12%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
1 051
|
1 051
|
1 188
|
1 188
|
1 188
|
1 188
|
1 188
|
1 188
|
1 188
|
1 254
|
1 254
|
1 254
|
1 254
|
1 254
|
1 254
|
1 255
|
1 255
|
1 255
|
1 254
|
1 254
|
1 977
|
1 977
|
1 977
|
1 977
|
|
Switch to:
Switch to:
See Also
Discover More
